BODALCHEMBodal Chemicals Limited Forensic Risk Analysis

Dyes And Pigments
Risk ClassWatch
Market Cap₹589 Cr
Primary DriverGovernance
Flagium AI Risk Score
Early signs of stress detected. Not yet widespread, but initial deterioration is visible.
30 / 100
-5 QoQ
Improving
Sentinel Insight

Financial profile remains stable for now. Pressure is receding in governance. This suggests the risk profile is currently stabilizing. Risk levels are improving.

50.0th %ile (Sector)Accel: +0 Qtrs
Updated2026-06-02
Market View
73.350%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Stability Adjustment
+30.0 pts
Final Composite Risk30 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 1030 over 13 quarters.

Expected Direction
🟢 Improving
Primary Deterioration Drivers
  • Inventory Stress
  • Industrial Margin Stress
  • Working Capital Expansion
What to Watch Next Quarter
  • Operating profit margins
  • Working capital efficiency
  • Inventory turnover

Active Risk Objects (8)

CriticalHigh
Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2024
Aggressive Capex (44.2%) amidst slow revenue growth (-15.5%).

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Industrial Margin Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight12/15
MomentumAccelerating
Last SignalQ3 FY2026
BODALCHEM: EBITDA margin compressed by 2.8 bps YoY.

"Margins are in freefall. Operating costs are growing significantly faster than revenue."

Low Interest Coverage
💧 Liquidity & CoverageQuarterlyActive for 11 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ3 FY2026
BODALCHEM: Low Interest Coverage Ratio of 1.01x in FY2026 Q3 (Threshold: 2.5x).

"The ability to cover interest is strengthening as earnings improve or debt is retired."

Profit Collapse
📊 Earnings QualityQuarterlyActive for 6 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ3 FY2026
BODALCHEM: Net Profit collapsed by 95.5% from FY2025 Q3 to FY2026 Q3.

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Negative FCF Streak
⚖️ Governance SignalsAnnualActive for 1 Years
More Detail
Impact Weight6/15
MomentumDecaying
Last SignalFY2024
BODALCHEM: Negative Free Cash Flow for last 3 consecutive years.

"Free cash flow pressure is easing as capital intensity or working capital stress recedes."

Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 1 Years
More Detail
Impact Weight10/15
MomentumDecaying
Last SignalQ4 FY2025
Working capital expansion detected: Receivable days increased by -7.8%.

"Working capital pressure is receding. Cash previously locked in operations is being released."

Inventory Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumDecaying
Last SignalQ4 FY2025
Inventory growth (26.2%) significantly outpaced revenue growth (13.6%).

"Inventory overhang is clearing. Stock levels are normalizing as sales momentum returns."

Revenue-Debt Divergence
🏛️ Solvency & LeverageAnnualActive for 1 Years
More Detail
Impact Weight6/15
MomentumDecaying
Last SignalFY2024
BODALCHEM: Revenue fell 10.5% while Debt rose 20.6% in 2024 vs 2023.

"Debt servicing metrics have improved recently. The company is actively deleveraging."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)6.837.19✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+36.0+36.0✅ RESILIENT
Forensic Benchmark Context: Dyes And Pigments (n=7 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
73.35(+0%)
1M Divergence+5.51%
1 Week-1.86%
1 Month+7.77%
6 Months+40.62%
1 Year-1.41%
2 Year+3.38%
3 Year+12.47%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The risk profile is Early Signals and currently improving. Recent structural triggers in governance suggest a building pressure on the underlying framework. Material forensic traces are visible in structural transparency and audit trails, indicating a progressive erosion of structural stability. Initial structural recovery is visible; monitor for a sustained return to resilience.

BODALCHEM • MARKET STRUCTURE

Stage 1 — Accumulation

The company is in a foundational phase. Risk metrics are stabilizing as the company builds a base for potential future fundamental improvement.

Stage Transition Prob.89%
Trend QualityDeveloping
Phase Progression
Phase Progression Score85%
Readiness LabelHigh (Phase Transition Imminent)
Probability of Advancing89%
CoinTree Momentum
Composite Z-Score+1.2363σ
Strong positive momentum leadership
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#185 of 2716
Top 6.81% in momentum strength
Timeframe Sparklines
1W-1.9%
1M+7.8%
6M+40.6%
Weinstein Indicators
150 DMA56.31
200 DMA58.53
150 DMA Slope+1.8865%Rising
Relative Strength+41.75%Leading
Relative Turnover (RTR)2.1638
ParticipationHealthy

PEER COMPARISON

Ranked comparison against sector peers

Risk profile is broadly in line with the Sector Mean (30).

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
10100th %ile
VS Sector Median (8.5)
Balance Sheet Stress
10100th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
10100th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Industrial Margin Stress

2026

Industrial Margin Stress

2025

Inventory Stress

2025

Working Capital Expansion

2024

Capex Efficiency Stress

2024

Negative FCF Streak

2024

Revenue-Debt Divergence

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY20262,05448176800
FY20251,75719114906
FY20241,4196204841
FY20231,58638285697